KETESSE

This brand name is authorized in Austria, Ecuador, Estonia, Finland, France, Hong Kong SAR China, Lithuania, Nigeria, Poland, Singapore, South Africa, Spain.

Active ingredients

The drug KETESSE contains one active pharmaceutical ingredient (API):

1	Dexketoprofen UNII N674F7L21E - DEXKETOPROFEN TROMETHAMINE
	Dexketoprofen belongs to the non-steroidal anti-inflammatory group of drugs. The mechanism of action of Dexketoprofen is related to the reduction of prostaglandin synthesis by the inhibition of cyclooxygenase pathway. Furthermore, the inhibition of the synthesis of prostaglandins could affect other inflammation mediators such as kinins, causing an indirect action which would be additional to the direct action.
	Read more about Dexketoprofen

Medication package inserts

Below package inserts are available for further reading:

Document	Type	Information Source
KETESSE Film-coated tablets	MPI, Generic	Health Products Regulatory Authority (ZA)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
M01AE17	Dexketoprofen	M Musculo-skeletal system → M01 Antiinflammatory and antirheumatic products → M01A Antiinflammatory and antirheumatic products, non-steroids → M01AE Propionic acid derivatives
Discover more medicines within M01AE17

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
EC	Agencia Nacional de Regulación, Control y Vigilancia Sanitaria	29136-01-10, 29890-07-11
EE	Ravimiamet	1211487, 1211498, 1211500, 1211511, 1211522, 1211533, 1211601, 1211612, 1211623, 1211645, 1211656, 1211667, 1211678, 1211689, 1211690, 1211702, 1211713, 1211724, 1211735, 1487875, 1487886, 1487897, 1487909, 1487910, 1487921, 1487932, 1487943, 1487965, 1487976, 1487987, 1487998, 1488001, 1488012, 1488023, 1488034, 1531662, 1726411, 1726422, 1753781, 1753792, 1753804
ES	Centro de información online de medicamentos de la AEMPS	60930, 66820
FI	Lääkealan turvallisuus- ja kehittämiskeskus	047187, 047242, 399866, 515759, 599021
FR	Base de données publique des médicaments	60205458, 62128284, 63929235, 64613432
HK	Department of Health Drug Office	58745, 58761
LT	Valstybinė vaistų kontrolės tarnyba	1021715, 1021716, 1021717, 1021718, 1021719, 1021720, 1021721, 1021730, 1021731, 1021732, 1021733, 1021734, 1021735, 1021736, 1021737, 1021738, 1021739, 1021740, 1025037, 1055615, 1055616, 1061528, 1061529, 1061530, 1061531, 1061532, 1061533, 1061534, 1061535, 1061536, 1061537, 1061538, 1061539, 1061540, 1061541, 1061542, 1082354, 1082355, 1084246, 1084247, 1084248
NG	Registered Drug Product Database	B4-3530
Switch country to Nigeria in order to find specific presentations of KETESSE
PL	Rejestru Produktów Leczniczych	100163182, 100250372, 100376021
SG	Health Sciences Authority	12650P, 14889P
ZA	Health Products Regulatory Authority	54/2.7/0534, 54/2.7/0536